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1. Introduction
   Diabetes mellitus worldwide has shown an alarming upsurge, 
ranking it as the fourth or fifth leading cause of death in the world. 
It is associated with serious complications including coronary 
artery and peripheral vascular disease, stroke, diabetic neuropathy, 
amputations, renal failure and blindness[1]. 
   The current rapid global rise in diabetes rate is attributed to rapid 
rise in unhealthy life styles, urbanization and aging[2]. Global 
estimate of the number of diabetics within the past three decades 
showed an increase from 153 million in 1980 to 347 million in 
2008. Currently the prevalence of diabetes is estimated at 382 
million people in 2013 and is expected to rise to 592 million by the 
year 2035. With this high prevalence, the highest mortality due to 
diabetis mellitus occurs in low and middle income countries[1].
   Management of diabetes using traditional remedies is 
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widespread in Africa in rural as well as urban communities. An 
increasing number of patients opt for traditional remedies driven 
by a combination of factors including financial constraints and/or 
geographical accessibility of the population to orthodox antidiabetics, 
inadequacy of the healthcare systems, ease of accessibility of 
traditional medicine, indigenous knowledge of community members 
as well as the role of traditional healers[3,4]. 
   Sudan is characterized by a rich floral diversity and an equally 
rich ethnomedicinal tradition. Several herbal preparations have been 
used in folklore practice for the management of diabetes with claims 
asserting their hypoglycemic effect, which heightened the interest in 
further research to ascertain the basis of their antidiabetic properties. 
The hypoglycemic activity of many plants like Geigeria alata 
(G. alata) roots[5], Acacia nilotica pods[6], Balanites aegyptiaca 
fruits, Guiera senegalensis leaves, Hyphaene thebaica epicarp 
and Trigonella foenum-graecum seeds[7], used in Sudanese folk 
medicine has been reported during the last few years. However, 
the mainstream use of herbal medicines in Sudan is popularized by 
empirical lore of special groupsÊ experiences and personal contacts 
as in the case of some tribes in the Nuba Mountains (Western 
Sudan) who used some plants for the treatment of diabetes, yet these 
species are not commonly known for their hypoglycemic effect in 
other regions of the country. Such plant species are exemplified by 
Mitragyna inremis (Wild) O. Kundze (M. inremis), Nauclea latifolia 
Smith (N. latifolia), Randia nilotica Stapf. (R. nilotica), Tinospora 
bakis (A.Rich.) Miers (T. bakis) and Striga hermonthica (Del.) Benth 
(S. hermonthica ) which are used in The Nuba Mountains region for 
the management of diabetes (personal communication). However, 
some of these species are used for other ailments according to the 
experience in other parts of the country where S. hermonthica is 
used in Central Sudan against leukoderma[8] and T. bakis for the 
treatment of sleeping sickness in South Eastern Sudan[9]. A similar 
experience to that of Nuba Mountains groups is evident in India and 
Turkey where another Tinospora species, Tinospora cordifolia, is 
known for its antidiabetic effect[10,11]. The use of M. inremis and 
N. latifolia as antidiabetic in the Nuba Mountains is similar to the 
practice of Hausa/Fulani tribes of Northern Nigeria, with differences 
in plant organ used, where the stem bark of the former[12] and leaves 
of the latter[13] were found to have hypoglycemic effect in alloxan 
induced diabetic Wistar rats. Therefore, the objective of this study 
was to investigate the hypoglycaemic effect of aqueous extracts from 
M. inremis, N. latifolia, R. nilotica, T. bakis and S. hermonthica.
2. Materials and methods
2.1. Plant materials
   Plant materials from the five plant species were collected from the 
Nuba Mountains in Western Sudan on December 2012. Botanical 
identification and authentication were performed in the Botany 
Department Herbarium, Faculty of Science, University of Khartoum, 
Sudan. The identities, parts used and voucher specimen numbers of 
the investigated plants are shown in Table 1.
Table 1 
Name, family, voucher number and part studied of the investigated plants.
Plant Latin name Family
Vernacular 
name
Voucher No. Part used
M. inremis Rubiaceae Hikmat 2013-12/HBD Fruits
N. latifolia Rubiaceae Karmadoda 2013-13/HBD Fruits
R. nilotica Rubiaceae Kir Kir 2013-14/HBD Fruits
T. bakis Menispermaceae Irg alhager 2013-15/HBD Seeds
S. hermonthica Scrophulariaceae Boda 2013-16/HBD Whole plant
2.2. Preparation of aqueous crude extracts
   The studied parts of the plant materials were shade-dried and 
then ground to powder. Aqueous extract was prepared by simple 
maceration of 500 g of powdered sample in 1 500 mL of distilled 
water maintained at ambient temperature for 4 h. Extract was first 
filtered on filter paper and then freeze-dried. The extract yields were 
33.5 g of M. inremis, 38.5 g of N. latifolia, 33.4 g of R. nilotica, 
42.3 g of T. bakis and 30.5 g of S. hermonthica. Each extract was 
dissolved in distilled water before its administration to the diabetic 
rats. For treatments, the concentration of aqueous extract was 400 
mg/5 mL/kg body weight. This was prepared by dissolving 2 g of 
plant extract in 25 mL water in a falcon tube in a hot water bath with 
vigorous shaking. The dose of each extract was calculated according 
to body weight before administration to the diabetic rats.
2.3. Animals and experimental design
   Wistar rats of either sex, aged 60 days and weighing 200ă250 g, 
were obtained from the Medicinal and Aromatic Plants Research 
Institute, Khartoum, reared in the premises of the Institute under 
illumination at night and early morning, with feed and drinking 
water provided ad libitum. This work was carried out according to 
the international regulations for the use of laboratory animals. Prior 
to experimental treatment, animals were fasted an overnight, but 
were allowed free access to water.
2.4. Acute oral toxicity study
   The acute oral toxicity study was conducted using test guidelines 
on acute oral toxicity test 423 according to Organisation for 
Economic Cooperation and Development[13]. A limit dose of 2 000 mg/
kg body weight /oral was used. The signs of toxic effects and/or 
mortality were observed 3 h after administration then for the next 48 h. 
The body weight was recorded for consecutive 14 days. Since the 
extracts were found safe up to the dose level of 2000 mg/kg body 
weight, a dose of 400 mg/kg body weight of the different plants 
extracts was selected for screening of the antidiabetic activity.
2.5. Induction of diabetes mellitus
   Diabetes was induced by intraperitoneal injection of 55 mg/kg 
body weight of streptozotocin (STZ) (Sigma, St Louis, MO, USA) 
dissolved in freshly prepared citrate buffer (0.1 mol/L, pH 4ï5). 
Fasting blood sugar for the animals was measured after 72 h using 
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Medisafe Mini Blood Glucose Reader (TERUMO Corporation Ltd., 
Hatagaya, Tokyo, Japan). Rats with fasting blood sugar level 200 
mg/dL were considered diabetic[14].
2.6. Oral glucose tolerance test with extracts in diabetic rats
   Fourty eight rats (42 diabetic surviving rats and 6 normal 
rats) were divided into eight groups of six rats each. In Group 
1, normal rats were treated with distilled water and used as the 
negative control. In Group 2, diabetic control rats were treated 
with distilled water. In Group 3, diabetic rats were given standard 
drug glibenclamide (5 mg/kg body weight). Groups 4, 5, 6, 7 and 
8 served as diabetic rats given M. inremis, N. latifolia, R. nilotica, 
T. bakis and S. hermonthica aqueous extracts at dose of 400 mg/
kg respectively. All the diabetic rats were fasted overnight (14 h) 
before the oral glucose tolerance test was done. Thirty minutes 
following the extracts or glibenclamide treatment, each rat was 
given an oral glucose load of 3 g/kg body weight. Blood samples 
were withdrawn from retro-orbital site at intervals of 60, 120 and 
180 min of glucose administration.
2.7. Chronic treatment with extracts
   The experimental rats were randomly divided into seven groups 
of six rats each: Group I, normal control rats; Group II, untreated 
diabetic rats; Groups III, IV, V,VI and VII are M. inremis, N. 
latifolia, R. nilotica, T. bakis and S. hermonthica treated diabetic 
rats respectively. In the case of extracts-treated diabetic rats, the 
extracts were administered orally at a dose of 400 mg/kg per 5 mL 
water once daily for 14 days. Normal control rats and untreated 
diabetic rats received equal volumes of water in place of the 
extract. The body weight was measured every day and the dose was 
calculated accordingly. 
2.8. Collection of blood samples and estimation of 
biochemical parameters
   At the end of the experimental period, day 14, the animals 
were fasted an overnight and the rats were sacrificed by cervical 
decapitation and fasting blood samples were collected in tubes 
with heparin. For serum samples, blood was allowed to coagulate, 
followed by centrifugation at 3 000 r/min for 15 min at 4 °C to 
separate serum. Sera were divided into aliquots and stored at -80 
°C for biochemical assay.
2.9. Biochemical analysis
   For biochemical analysis we used standard commercial kits 
according to the manufacturerÊs protocol. Fasting serum glucose 
level was determined on day 15 by glucose oxidase-peroxidase 
method using the kit of RANDOX Laboratories Ltd, UK. Serum 
total cholesterol (TC), serum triglycerides (TG), and high density 
lipoprotein-cholesterol (HDL-C)] were also measured using kits 
from Randox Laboratory Ltd. Low density lipoprotein-cholesterol 
(HDL-C) was calculated as follows: HDL-C = TC - TG / 5 - HDL. 
Serum creatinine, alanine aminotransferase (ALT), aspartate 
aminotransferase (AST) and lactate dehydrogenase (LDH) were 
measured using kits from Randox Laboratory Ltd., UK. Serum urea 
was determined using a commercial kit from QUIMICA Clinica 
Aplicada, Amposta, Spain. Blood urea nitrogen was calculated by 
the following formula: Blood urea nitrogen (mg/dL) = urea (mg/
dL) ė 0.467.
2.10. Histopathology
   Small pieces (5ă8 mm) of tissue from the liver in all groups 
were excised and were immediately fixed in 10% neutral 
buffered formalin. Fixed samples were trimmed and processed 
for paraffin embedding. Sections (5ă7 μm) were cut and picked 
up on clean silane-coated glass slides. After de-waxing and 
rehydration through descending concentrations of ethanol, the 
sections were stained with haematoxylin and eosin and examined 
microscopically.
2.11. Statistical analysis
   All values are expressed as mean μ SE. Statistical analysis was 
performed by One-way analysis of variance followed by TukeyÊs 
multiple comparison tests. The results were considered statistically 
significant if P is < 0.05.
3. Results
3.1. Acute toxicity study
   The different plants aqueous extracts were safe up to a dose of 
2000 mg/kg body weight. Behavior of the animals was clearly 
observed for the first 8 h then at an interval of every 4 h during the 
next 48 h, the extracts did not produce significant changes in the 
behavior of the animals or mortality.
3.2. Effect of plants aqueous extracts on oral glucose 
tolerance in diabetic rats
   Blood glucose level of the normal control rats, STZ induced 
diabetic control rats and diabetic rats treated with glibenclamide 
and different aqueous extracts dosed at 400 mg/kg at different 
time points (0, 60, 120 and 180 min) after oral administration of 
glucose (2 g/kg) is shown in Figure 1. In the diabetic control rats, 
the peak increase in blood glucose level was observed after 60 min 
and remained high over the next 120 min. Aqueous extracts of T. 
bakis, N. latifolia and R. nilotica significantly reduced (P < 0.05) 
the blood glucose level at 60 min and remained low over the next 
120 min when compared with the diabetic control rats. However, 
the aqueous extract of S. hermonthica induced an insignificant 
reduction in the blood glucose level at 120 min followed by a 
significant increase (P < 0.05) at 180 min to a level approaching 
that of diabetic control rats. M. inremis did not exert any change in 
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blood glucose level of the diabetic rats.
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Figure 1. Effect of plants aqueous extracts on oral glucose tolerance in 
STZ induced diabetic rats.
Values are expressed as mean μ SE (n = 6); *: P < 0.05 by comparison 
with normal rats; **: P < 0.05 by comparison with diabetic control rats. 
Time
3.3. Effect of plants aqueous extracts on body weight
   Results of the effect of different plants aqueous extracts at 
400 mg/kg/day dose on body weight of STZ induced diabetic rats 
after 2 weeks of treatment are presented in Figure 2. By the end of 
second week, diabetic rats gained less body weight with significant 
reduction (25%) (P < 0.05) to the normal control rats. Only aqueous 
extract of T. bakis improved the body weight of diabetic rats with 
significant increase (21%) (P < 0.05) compared to the diabetic 
control rats. Aqueous extract of S. hermonthica significantly reduced 
(P < 0.05) the body weight of diabetic rats (26%) compared to 
diabetic control rats. The differences in body weight of diabetic rats 
treated with other plant aqueous extracts were not significant.
Figure 2. Effect of plants aqueous extracts on body weight of STZ induced 
diabetic rats after 2 weeks treatment.
Values are expressed as mean μ SE (n = 6); A: Normal control; B: Diabetic 
(STZ); C: M. inremis; D: N. latifolia; E: R. nilotica; F: S. hermonthica; G: 
T. bakis; H: Glibenclamide. Different letters indicate differences among 
the groups (P < 0.05). 
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3.4. Effect of plants aqueous extracts on fasting blood glucose
   Results of the effect of different plants aqueous extracts at 400 mg/kg/
day dose on fasting blood glucose of STZ induced diabetic rats 
after 2 weeks of treatment are presented in Figure 3. The blood 
glucose concentration of diabetic rats increased significantly (P < 
0.05) (by 500%) compared to the normal control rats. However, 
treatment of diabetic rats with aqueous extracts of R. nilotica, M. 
inremis, N. latifolia and T. bakis significantly reduced (P < 0.05) the 
blood glucose concentration (70%, 42%, 26% and 16% reduction, 
respectively). S. hermonthica aqueous extract exerted negative effect 
where the blood glucose increased significantly (P < 0.05) (12% 
rise) compared to the diabetic control rats.
Figure 3. Effect of plants aqueous extracts on fasting blood glucose in 
STZ induced diabetic rats after 2 weeks treatment. 
Values are expressed as mean μ SE (n = 6); A: Normal control; B: Diabetic 
(STZ); C: M. inremis; D: N. latifolia; E: R. nilotica; F: S. hermonthica; G: 
T. bakis; H: Glibenclamide. Different letters indicate differences among 
the groups (P < 0.05).  
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3.5. Effect of plants aqueous extracts in serum lipid profiles
   Results of the effect of different plants aqueous extracts at 400 mg/kg/
day dose on serum lipid profiles of STZ induced diabetic rats after 2 
weeks of treatment are presented in Table 2.
Table 2 
Effect of plants aqueous extracts on total lipids profile in STZ induced 
diabetic rats after 2 weeks treatment.
Group
Total cholesterol 
(mg/dL)
Triglyceride 
(mg/dL)
HDL-C 
(mg/dL)
LDL-C 
(mg/dL)
Normal control 28.41 μ 1.90a 22.05 μ 3.00a 11.04 μ 0.10a 12.96 μ 6.70a
Diabetic (STZ) 63.65 μ 3.50b 43.81 μ 1.40b   9.13 μ 0.20b 45.76 μ 9.90b
M. inremis + STZ 35.68 μ 9.70c 27.18 μ 3.80a  12.47 μ 0.90ac  17.77 μ 6.70ac
N. latifolia + STZ 42.04 μ 8.70b 21.04 μ 1.90a 11.82 μ 0.10b 26.01 μ 7.30c
R. nilotica + STZ 43.05 μ 7.90b 17.91 μ 3.60a 15.44 μ 0.20c 24.03 μ 6.40c
S. hermonthica + STZ 70.50 μ 7.10b 19.42 μ 7.90a 12.17 μ 0.20b 53.84 μ 5.70b
T. bakis + STZ 37.03 μ 4.70c 29.93 μ 2.00a 14.58 μ 0.10c 16.46 μ 5.90ac
Glibenclamide + STZ 30.46 μ 1.90a 26.11 μ 1.40a 12.00 μ 0.10a 15.66 μ 8.70a
Values are expressed as mean μ SE (n = 6); Values with different superscript 
letters indicate differences among the groups (P < 0.05).
3.5.1. Changes on total cholesterol levels
   Diabetic rats showed significantly high level (P < 0.05) of 
total cholesterol (124% compared to the normal control rats). A 
significant decrease (P < 0.05) (44% and 42%) was observed in 
total cholesterol of diabetic rats given M. inremis and T. bakis 
respectively, whereas an insignificant decrease was observed for 
diabetic rats given N. latifolia and R. nilotica aqueous extracts 
compared to the diabetic control rats. Diabetic rats given S. 
hermonthica aqueous extracts showed a slight but insignificance 
increase in total cholesterol level.
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3.5.2. Changes on total triglycerides levels
   Diabetic rats showed significantly high level (P < 0.05) of 
total trigycerides (99% compared to the normal control rats). 
Administration of aqueous extracts from all plants under study for 
two weeks significantly (P < 0.05) decreased total triglycerides in 
all diabetic rats compared to their corresponding control. Percentage 
reduction in total triglycerides after treatments ranged from 59% in 
case of R. nilotica to 56% in S. hermonthica, 52% in N. latifolia, 
38% in M. inremis and 32% in T. bakis. Thus, treatment of diabetic 
rats with different plants extracts enabled them to reduce the total 
triglycerides to levels comparable to that of normal controls.
3.5.3. Changes on HDL-C level
   Diabetic rats showed insignificantly low level of HDL-C. Treatment 
of diabetic rats with different extracts induced a significant increase 
(P < 0.05) in HDL-C compared to the diabetic controls (69% in 
R. nilotica, 60% in T. bakis, 37% in M. inremis). However, an 
insignificant increase was observed in case of diabetic rats treated 
with aqueous extracts from S. hermonthica and N. latifolia. 
Interestingly, values of HDL-C in diabetic rats treated with R. nilotica 
and T. bakis were significantly (P < 0.05) higher than those of 
normal control rats.
3.5.4. Changes on LDL-C level
   Diabetic rats showed highly significant (P < 0.05) HDL-C level 
(253% compared to the normal control rats). Treatment of these rats 
with T. bakis, M. inremis, R. nilotica and N. latifolia aqueous extracts 
resulted in significant reduction in the level of HDL-C (P < 0.05), 
corresponding to percentage reduction of 64%, 61%, 47% and 43% 
respectively. However, in diabetic rats treated with S. hermonthica 
aqueous extract there was no significant change in the level of 
HDL-C. Yet, treatment of diabetic rats with T. bakis and M. inremis 
aqueous extracts resulted in lowering HDL-C to a level closer to that 
of normal control rats.
3.6. Effect of plants aqueous extracts on diabetic liver 
function markers 
   Liver function markers (AST, ALT and LDH) in diabetic rats treated 
for 2 weeks with plants aqueous extracts at 400 mg/kg/day are 
presented in Table 3.
Table 3 
The effect of plants aqueous extracts on liver function markers in STZ 
induced diabetic rats after 2 weeks of treatment.
Group AST (IU/L) ALT (IU/L) LDH (IU/L)
Normal control 14.55 μ 0.63a 18.91 μ 0.56a 12.54 μ 0.40a
Diabetic (STZ) 16.65 μ 0.15b 33.60 μ 7.75b 15.03 μ 1.25b
M. inremis + STZ 19.23 μ 3.74c 19.95 μ 1.42a 12.28 μ 0.60a
N. latifolia + STZ 11.54 μ 0.25a 23.68 μ 0.66a 17.88 μ 0.35c
R. nilotica + STZ 12.70 μ 1.38a 27.10 μ 3.35b 14.41 μ 1.62b
S. hermonthica + STZ  15.67 μ 0.16ab 21.31 μ 0.73a 14.45 μ 0.65b
T. bakis + STZ 13.36 μ 1.35a 27.42 μ 2.45b 14.06 μ 0.70b
Values are expressed as mean μ SE (n = 6); Values with different superscript 
letters indicate differences among the groups (P < 0.05).
3.6.1. Changes in activity of plasma AST 
   In diabetic control rats the activity of plasma AST was significantly 
(P < 0.05) increased (14% relative to normal levels). After treatment 
of diabetic rats with N. latifolia, R. nilotica and T. bakis aqueous 
extracts, the level of AST was significantly (P < 0.05) decreased by 
31%, 24% and 20% respectively to reach values closer to normal 
level, though treatment of diabetic rats with M. inremis aqueous 
extracts increased it significantly (P < 0.05) by 15% as compared 
to the diabetic control rats. However, treatment with S. hermonthica 
aqueous extracts did not significantly affect the AST level.
3.6.2. Changes in activity of plasma ALT
   In diabetic control rats the activities of plasma ALT was 
significantly (P < 0.05) increased by 78% relative to normal level. 
The level of ALT was back closer to normal value after treatment 
with M. inremis aqueous extracts, whereas treatment of diabetic rats 
with S. hermonthica and N. latifolia aqueous extracts significantly 
reduced (P < 0.05) the level of ALT by 37% and 30% respectively 
compared to the diabetic control rats. An insignificant decrease was 
observed for the diabetic rats treated with R. nilotica and T. bakis 
aqueous extracts.
3.6.3. Changes in activity of LDH
   A significant increase (P < 0.05) (20% relative to normal level) 
in LDH was observed in the diabetic control rats. As observed for 
ALT activity, the level of LDH was back closer to normal value after 
treatment with M. inremis aqueous extract. However, N. latifolia 
aqueous extract increased significantly (P < 0.05) the level of LDH 
by 19% as compared to the diabetic control rats. R. nilotica, S. 
hermonthica and T. bakis aqueous extracts did not exert a significant 
effect.
3.7. Effect of plants aqueous extracts on diabetic kidney 
function markers 
   Results of the effect of plant aqueous extracts at 400 mg/kg/day on 
kidney function markers (creatinine, urea and blood urea nitrogen) in 
STZ induced diabetic rats after 2 weeks are presented in Table 4. 
Table 4 
The effect of plants aqueous extracts on kidney function markers in STZ 
induced diabetic rats after 2 weeks of treatment.
Group Creatinine 
(mg/dL)
Urea 
(mg/dL)
Blood urea nitrogen 
(mg/dL)
Normal control 0.49 μ 0.08a 42.92 μ 2.06a 0.27 μ 0.01a
Diabetic (STZ) 0.99 μ 0.12b 60.22 μ 2.54b 0.38 μ 0.01b 
M. inremis + STZ 0.73 μ 0.07b 27.27 μ 0.49c 0.19 μ 0.01c
N. latifolia + STZ 0.77 μ 0.08b 54.59 μ 0.98a 0.31 μ 0.02a
R. nilotica + STZ 0.58 μ 0.07a 57.67 μ 3.06b 0.37 μ 0.01b 
S. hermonthica + STZ 0.53 μ 0.07a 80.78 μ 3.46d 0.56 μ 0.00d
T. bakis + STZ 0.60 μ 0.03a 51.96 μ 1.12a 0.29 μ 0.02a  
Values are expressed as mean μ SE (n = 6); Values with different superscript 
letters indicate differences among the groups (P < 0.05).
3.7.1. Changes on level of creatinine
   In diabetic control rats, a significant increase in the level of 
creatinine was observed (P < 0.05) (102% compared to level of 
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normal control rats). However, treatment of diabetic rats with 
aqueous extracts of S. hermonthica, R. nilotica and T. bakis 
significantly (P < 0.05) reduced their creatinine levels by 46%, 41% 
and 39% respectively compared to the diabetic group, bringing the 
level closer to normal value. An insignificant reduction was observed 
for diabetic rats treated with aqueous extracts of M. inremis and N. 
latifolia. 
3.7.2. Changes on level of urea and blood urea nitrogen
   In diabetic control rats, the levels of urea and blood urea 
nitrogen were significantly increased (P < 0.05) by 40% and 41% 
respectively compared to normal control rats. When diabetic rats 
were treated with aqueous extracts of M. inremis, the urea level was 
reduced by 55% compared to diabetic control rats and 36% below 
the normal level. A similar result was observed for the blood urea 
nitrogen where a significant (P < 0.05) reduction by 50% compared 
to diabetic controls rats and 30% below the normal controls ones 
was occurred. Treatment of diabetic rats with T. bakis and N. latifolia 
aqueous extracts was able to bring the blood urea nitrogen closer to 
normal level. R. nilotica aqueous extract did not have a significant 
effect on both urea and blood urea nitrogen levels; however, S. 
hermonthica aqueous extract increased them significantly (P < 0.05) 
by 34% and 47% respectively compared to the diabetic control rats. 
3.8. Histopathology
   Images of sections of different rat groups are shown in Figure 4. 
Normal control rats (Figure 4A) showed more or less normal hepatic 
parenchymal organization, with normal portal tracks and sinusoids. 
Unlike other rats, the sinusoids of normal controls did not show 
hypertrophied Kupffer cells. Sections of the diabetic control rats 
(Figure 4B) seemed to reflect friable parynchemal architecture with 
intense infiltration of polymorph leucocytes in portal triads zones. 
Hypertrophied Kupffer cells ran along the sinusoids, and hepatocytes 
at different stages of necrosis could be detected; in addition, there 
was hemorrhage into foci of lysed hepatocytes. Histopathological 
features in sections of rats treated with different extracts (except S. 
hermonthica) (Figures 4Că4F) were not markedly different from 
each other. The main features in liver sections from these groups 
were infiltration of portal tracks with polymorph leucocytes and 
hypertrophied Kupffer cells. Hemorrhage was less frequently 
detected compared to diabetic control, indicating a degree of healing 
process. However, in sections from rats treated with S. hermonthica 
extract (section not shown), there were more intense infiltration 
with polymorph leucocytes and more hemorrhagic foci compared to 
others; moreover, more hepatocytes with pyknotic nuclei and more 
necrosis were observed.
4. Discussion
   The rising cost of medical care in Sudan is increasingly driving 
patients to herbal medicine and in case of diabetes, emerging 
experience with certain plants drew attention to some communities 
rarely known for such experience in the country. In the Nuba 
Mountains, Western Sudan, it emerged that plant species including 
M. inremis, N. latifolia, R. nilotica, T. bakis and S. hermonthica have 
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Figure 4. Light micrograph of liver sections representative for rats given aqueous plant extracts at 400 mg/kg/day oral dose (H & E).
A: Normal control rats; visible is normal hepatic parenchyma with more or less normal portal triads and sinusoids; B: Diabetic control rats showing 
hemorrhagic foci replacing necrotic hepatocytes (asterisks). Arrows indicate infiltration of leucocytes in portal triads. Visible also are hypetrophied 
Kupffer cells along hepatic sinusoids, and hepatocytes at various stages of degeneration; C: Diabetic rats treated with M. inremis showing leucocytic 
infiltration proliferating bile canaliculi (arrows); also seen are hypertrophied Kupffer cells along sinusoids; D: Diabetic rats treated with N. latifolia; the 
image shows leucocytic infiltration in portal triad (arrows) and thickening of the portal artery wall. Hypertrophied Kupffer cells are also seen along the 
sinusoids; E: Diabetic rats treated with R. nilotica; the image shows leucocytic infiltration in portal triads (arrows); F: Diabetic rats treated with T. bakis; 
the image shows leucocyic infiltration in portal triad (arrow) and hemorrhage (asterisks). Seen also are hypertrophied Kupffer cells along sinusoids.
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been used for the management of diabetes. However, hypoglycemic 
herbs are used by many communities in other countries to treat 
hyperglycemia and hyperlipidemia precipitated by disturbed glucose 
and lipid metabolism in diabetes mellitus. The current results 
confirm the potential of a number of herbs in the control of glucose 
level as observed for rats given aqueous extracts of T. bakis, N. 
latifolia and R. nilotica at 400 mg/kg. The extracts of the three plants 
significantly improved glucose tolerance in diabetic rats suggesting 
that they enhanced insulin secretion as reported in similar results 
for the hypoglycemic effect of G. alata[5]. Moreover, the two-week 
treatment of diabetic rats with R. nilotica, M. inremis, N. latifolia 
and T. bakis aqueous extracts resulted in significant (P < 0.05) 
antihyperglycemic effect. Interestingly, M. inremis did not exert 
an effect upon testing oral glucose tolerance of diabetic rats but a 
significant reduction in glucose level was observed after two-week 
treatment. Relevant to our findings is the demonstration by Gidado 
et al.[15] that the aqueous and ethanolic extracts of N. latifolia leaves 
had a significant antihperglycemic effect on fasting blood glucose 
levels in streptozotocin-induced diabetic rats in a dose-dependent 
manner.  
   Diabetic rats manifested significant (P < 0.05) reduction in body 
weight concomitant with hyperglycemia. Protein-energy wasting 
accompanying hyperglycemia has been attributed to altered glucose 
metabolism as indicated by Rajasekar et al.[16] in their experiments 
with diabetic rats where failure of body cells to utilize glucose as 
energy source seems to have ushered proteins as an alternative 
energy source leading to metabolic imbalance in protein metabolism 
with consequent loss of body weight or continuous excretion of 
glucose from the body[16-18]. Oral administration of T. bakis aqueous 
extract for 14 consecutive days to diabetic rats improved their body 
weight, which could be due to better control of the hyperglycemic 
state in these rats. However, aqueous extracts of N. latifolia, R. 
nilotica and M. inremis did not improve the body weight of diabetic 
rats.
   Diabetic rats exhibited abnormalities in lipid metabolism as 
evidenced from the elevated levels of cholesterol, triglycerides and 
high levels of low density lipoprotein cholesterol and low levels of 
HDL-C[19,20]. Two-week treatment of diabetic rats with T. bakis, M. 
inremis, R. nilotica and N. latifolia aqueous extracts significantly (P 
< 0.05) ameliorated the serum lipid levels in diabetic rats and thus 
could be beneficial in preventing diabetic complications as well as 
improving lipid metabolism in diabetics[21]. A similar hypolipidemic 
effect was reported in diabetic rats given ethanol extract of N. 
latifolia leaves where significant reduction of TG, HDL-C, VHDL-C 
and total cholesterol were observed as well as significant elevation 
of HDL-C[22]. 
   The increment in the activities of plasma AST, ALT and LDH 
indicated that diabetes may induce hepatic parenchymal injury 
and hepatic dysfunction[23,24] and leakage of these enzymes from 
the liver cytosol into the blood stream[24,25]. On the other hand, 
treatment of the diabetic rats with either N. latifolia, R. nilotica or 
T. bakis brought back the activity of AST enzyme to normal level 
whereas N. latifolia and M. inremis caused reduction in the activity 
of ALT closer to normal level. The LDH level of diabetic rats was 
only improved by M. inremis aqueous extract suggesting proper 
regulation of NAD+/NADH ratio[26].
   The elevation in the levels of plasma renal function parameters 
in diabetic rats is associated to renal dysfunction and metabolic 
disturbance[27,28]. In this study the effect of plants aqueous extracts 
on diabetic kidney function markers was variable; M. inremis 
induced significant (P < 0.05) reduction on levels of urea and blood 
urea nitrogen whereas T. bakis and R. nilotica reduced significantly 
(P < 0.05) the creatinine level. N. latifolia aqueous extract exerted 
only significant (P < 0.05) effect on blood urea nitrogen level.
   Daily oral administration of S. hermonthica aqueous extract to 
diabetic rats for 14 days appeared to increase the blood glucose 
level and decrease their body weight thus indicating that it has no 
antihyperglycemic effect. Moreover, although this aqueous extract 
reduced the triglyceride level and ALT activity of diabetic rats, the 
levels of cholesterol, low and HDL-C, urea and blood urea nitrogen 
of these rats were not improved. 
   Our findings demonstrated that the aqueous extracts of R. nilotica, 
M. inremis, N. latifolia and T. bakis had satisfactory efficacy in 
glycemic and lipidemic homeostasis in diabetic rats, and that they 
were apparently targeting more than one metabolic pathway. Their 
effects on different biochemical parameters were in a variable 
way, which might reflect the complexity of the phytochemicals 
and bioactivities in the plants regarding modulation of metabolic 
disturbances.
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Comments 
Background
   The objective of this research was to evaluate antidiabetic activity 
of aqueous extracts from some plants (M. inremis, N. latifolia, R. 
nilotica, T. bakis and S. hermonthica) used in Western Sudan on 
streptozotocin-induced diabetes rats.
Research frontiers
   The research in this paper demonstrated that the extracts from T. 
bakis, N. latifolia, R. nilotica and M. inremis have therapeutic value 
in diabetes and related complications, and thus supporting the use of 
these plants in Western Sudan traditional medicine.
Related reports
   The researches related to this paper also reported during the last 
few years as the use of G. alata roots, Acacia nilotica pods, Balanites 
aegyptiaca fruits, Guiera senegalensis leaves, Hyphaene thebaica 
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epicarp and Trigonella foenum-graecum seeds to hypoglycemia in 
Sudanese folk medicine.
Innovations and breakthroughs
   In the present work, authors have demonstrated the potential of 
some indigenous medicinal plants in the treatment of diabetes.

Applications
   The results of this work can be applied to support in the treatment 
of diabetes.
Peer review
   This research obtained interesting and valuable results. The 
authors have demostrated the effect of aqueous extracts from some 
indigenous plants in supporting the treatment of diabetes. 
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